With rising healthcare costs, more informed and engaged patients, and advancing technology, health wearables have seen a significant uptake in recent years.
With the advent of new targeted treatments and immunotherapies, Quintiles has provided clinical services for over 700 phase 1 and phase 2 oncology studies since 2011.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
